Elevance Health Reaffirms Targets as Shares Hold C Grade

• Our read: EasyAlpha grades Elevance Health Inc C, reflecting average quality among healthcare industry peers, where earnings quality leads and growth remains the key area to watch.
• The day: Shares rallied 4.9% to $416.54 after the company reaffirmed its annual profit targets.
• Watching: Third-quarter earnings scheduled for Tuesday, October 20.

Elevance Health surged on Thursday, climbing 4.9% to close at $416.54 on 2.1x its normal trading volume. The sharp advance marked the stock's eighth-largest daily gain over the past year and its largest single-day jump since Wednesday, July 15. Trading picked up after the company submitted a regulatory filing on Thursday morning. In the filing, the insurer reaffirmed its full-year 2026 financial guidance ahead of meetings with investors. Management reiterated its outlook for adjusted earnings of at least $27.00 per share and GAAP earnings of at least $20.10 per share. Management also indicated during an investor conference that third-quarter performance was tracking ahead of expectations.

EasyAlpha grades Elevance Health Inc C, indicating average quality among healthcare industry peers. In our historical research, companies graded A or B have shown stronger fundamentals and lower risk of severe drawdowns than those in the lowest tiers, while C represents a typical company for its industry. The company looks strongest at earnings quality, alongside a 2.5% profit margin. The company maintains a quarterly dividend payment of $1.72 per share.

The main watch item is growth. Quarterly revenue growth stood at +1.4% year over year. Even with muted sales growth, the stock is +18.8% so far this year and trades at 13.8 times forward earnings. Wall Street sentiment remains favorable, with 68.2% of 22 covering analysts carrying buy ratings and an average price target that sits 7.8% above Thursday's close.